Economics of diabetes-cost impact of not treating diabetes early and intensively.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cornerstone

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/S1098-3597(04)80054-1PMID 15628693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PPARs and the complex journey to obesity

  2004cited by this paper
• Obesity as the core of the metabolic syndrome and the management of coronary heart disease

  2004cited by this paper
• Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.

  2004cited by this paper
• Economic costs of diabetes in the US in 2002.

  2003cited by this paper
• Diabetes prevalence among American Indians and Alaska Natives and the overall population--United States, 1994-2002.

  2003cited by this paper
• Pancreatic beta-cell loss and preservation in type 2 diabetes.

  2003cited by this paper
• Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

  2003cited by this paper
• Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.

  2003cited by this paper
• The direct medical cost of type 2 diabetes.

  2003cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.

  2002cited by this paper
• Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

  2002cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.

  2001cited by this paper
• Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

  2001cited by this paper
• Insulin Resistance and Insulin Secretory Dysfunction Are Independent Predictors of Worsening of Glucose Tolerance During Each Stage of Type 2 Diabetes Development

  2000cited by this paper
• The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.

  2000cited by this paper
• The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

  1998cited by this paper
• Development of the multiple metabolic syndrome: an epidemiologic perspective.

  1998cited by this paper
• The Insulin Resistance Syndrome Revisited

  1996cited by this paper
• Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web

  1992cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper

• Prevalence of diabetes mellitus and its associated risk factor assessment among elderly in urban area of Punjab

  2019cites this paper
• Brazilian Morus nigra Attenuated Hyperglycemia, Dyslipidemia, and Prooxidant Status in Alloxan-Induced Diabetic Rats

  2017cites this paper
• Type 1 diabetes mellitus: An update

  2012cites this paper
• Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats.

  2011cites this paper
• Challenges in funding diabetes care: a health economic perspective

  2010cites this paper
• Effects of a physical activity and dietary education intervention in a population with type 2 diabetes mellitus

  2010cites this paper
• IMPACTO ECONÓMICO DE LA HIPERGLUCEMIA EN LA SALUD ORAL DE PACIENTES DIABÉTICOS TIPO 2

  2009cites this paper
• Diabetes mellitus: aspectos modernos de la problemática

  2007cites this paper
• Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats.

  2006cites this paper
• Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin.

  2006cites this paper